It is worthy to mention here that HFD-mediated reduction in hepatic ACSL4 protein levels in C57/BL6 mice occurs under conditions of excessive obesity, mild to moderate hyperglycemia, hyperinsulinemia, diabetes, and hepatic steatosis (13). The gene discussed is ACSL4; the disease is Hyperglycemia.